Synthesis and characterization of a new bile acid and platinum(II) complex with cytostatic activity

Journal of Lipid Research

Volumn 38, Issue 5, 1997, Pages 1022-1032

  Criado, J J ^a   Herrera, M C ^a   Palomero, M F ^a   Medarde, M ^a   Rodriguez, E ^a   Marin, J J G ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Antitumor; Cholyglycinate; Glycocholic acid; Metal cancer

Indexed keywords

BAMET H2; BILE ACID CONJUGATE; CISPLATIN; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOSTASIS; DRUG ACTIVITY; DRUG PURIFICATION; DRUG SOLUBILITY; DRUG SYNTHESIS; ISOLATED LIVER; LEUKEMIA L 1210; LIVER PERFUSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; GLYCOCHOLIC ACID; ORGANOPLATINUM COMPOUNDS; RATS;

EID: 0030918276     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Canon, J. L., Y. Humblet, and M. Symann. 1990. Resistance to cisplatin: how to deal with the problem. Eur. J. Cancer 26: 1-3.
2. Konno, T. 1992. Targeting chemotherapy for hepatoma: arterial administration of anticancer drugs dissolved in Lipiodol. Eur. J. Cancer, 28: 403-409.
3. Kramer, W., G. Wess, A. Enhsen, K. Bock, E. Falk, A. Hoffman, G. Neckermann, D. Gantz, S. Schulz, L. Nickau, E. Petzinger, S. Turley, and J. M. Dietschy. 1994. Bile acid-derived HMG-CoA reductase inhibitors. Biochim. Biophys. Acta. 1227: 137-154.
4. Kramer, W., G. Wess, G. Schubert, M. Bickel, A. Hoffmann, K. H. Baringhaus, A. Enhsen, H. Glombik, S. Mullner, G. Neckermann, S. Schulz, and E. Petzinger. 1993. Bile acids as carrier for drugs. In Bile Acids and the Hepatobiliary System. From the Basic Science to the Clinical Practice. G. Paumgartner, A. Stiehl and W. Gerok, editors. Kluwer Academic Publishers, Dordrecht, The Netherlands. 161-176.
5. Loeher, P. J., and L. H. Einhorn. 1984. Cisplatin. Ann. Int. Med. 100: 704-713.
6. Bradner, W. T., W. C. Rose, and J. B. Huftalen. 1980. Antitumor activity of platinum analogs. In Cisplatin: Current Status and New Developments. A. W. Prestayko, S. T. Crooke and S. K. Carter, editors. Academic Press, New York. 171-182.
7. Christian, M. C. 1992. The current status of new platinum analogs. Semin. Oncol. 19: 720-733.
8. Carey, M. C. 1985. Physical-chemical properties of bile acids and their salts. In Sterols and Bile Acids. H. Danielsson and J. Sjovall, editors. Elsevier Science Publishers, Amsterdam. 345-403.
9. Maeda, M., N. Takasuka, T. Suga, and T. Sasaki. 1990. New antitumor platinum(II) complexes with both lipophilicity and water miscibility. Jpn. J. Cancer Res. 81: 567-569.
10. Maeda, M., T. Suga, N. Takasuka, A. Hoshi, and T. Sasaki. 1990. Effect of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes on lung metastasis of B16-F10 melanoma cells in mice. Cancer Lett. 55: 143-147.
11. Hofmann, A. F. 1994. Biliary secretion and excretion: the hepatobiliary component of the enterohepatic circulation of bile acids. In Physiology of the Gastrointestinal Tract. L. R. Johnson, editor. Raven Press, New York. 1555-1576.
12. Marin J. J. G., R. I. R. Macias, M. C. Herrera, M. F. Palomero, M. J. Monte, G. R. Villanueva, M. Y. El-Mir, J. J. Criado, and M. A. Serrano. 1996. Liver and ileum transport of cytostatic platinated bile acids. Hepatology 24: 543, abstract.
13. Marin, J. J. G., M. C. Herrera, M. F. Palomero, R. I. R. Macias, M. J. Monte, G. R. Villanueva, M. Y. El-Mir, M. A. Serrano, and J. J. Criado. 1996. "In vivo" distribution, toxicity and cytostatic capacity of platinated bile acid analogs. Hepatology 24: 372A.
14. Setchell, K. D. R., and J. Worthington. 1982. A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse phase octadecylsilane-bonded silica cartridges. Clin. Chim. Acta. 125: 135-144.
15. Talalay, P. 1960. Enzymatic analysis of steroid hormones. Methods Biochem. Anal. 8: 119-143.
16. Berry, M. N., and D. S. Friend. 1969. High-yield preparation of isolated rat liver parenchymal cells. J. Cell Biol. 43: 506-520.
17. Labarca, C., and K. Paigen. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102: 344-352.
18. Marin J. J. G., P. Bravo, F. P. Barriocanal, M. Y. El-Mir, and G. R. Villanueva. 1991. Hyperglycemia-induced cholestasis in the isolated perfused rat liver. Hepatology 14: 184-191.
19. Miller L. L., C. G. Bly, M. L. Watson, and W. F. Bale. 1951. The dominant role of the liver in plasma protein synthesis. J. Exp. Med. 94: 431-445.
20. Paul, A. K., H. Mansuri-Torshizi, T. S. Srivastava, S. J. Chavan, and M. P. Chitnis. 1993. Some potential antitumor 2,2′-dipyridylamine Pt(II)/Pd(II) complexes with amino acids: their synthesis, spectroscopy, DNA binding, and cytotoxic studies J. Inorg. Biochem. 50: 9-20.
21. Kieft, J. A., and K. Nakamoto. 1967. Infrared spectra of some Platinum(II) glycine complexes. J. Inorg. Nucl. Chem. 29: 2561-2568.
22. Altman, J., T. Castrillo, W. Beck, G. Bernhardt, and H. Schönenberger. 1991. Metal complexes with biologically important ligands. 62. Platinum(II) complexes of 3-(2-aminoethoxy)strone and estradiol. Inorg. Chem. 30: 4085-4088.
23. Hanessian, S., and J. Wang. 1993. Design and synthesis of a cephalosporin-carboplatinum prodrug activatable by a β-lactamase. Can. J. Chem. 71: 896-906.
24. Khokhar, A. R., Q. Xu, and S. al-Baker. 1991. Synthesis and characterization of highly lipophilic antitumor Platinum(II) complexes. J. Coord. Chem. 24: 77-82.
25. 195Pt spectra of Platinum(II) peptide complexes and their growth-inhibitory activity against mouse meth A solid tumor in vivo. Bull. Chem. Soc. Jpn. 68: 2559-2565.
26. Lee, Y. A., O. S. Jung, C. O. Lee, S. U. Choi, M. J. Jun, and Y. S. Sohn. 1995. Cationic diamineplatinum (II) complexes of nalidixic acid. Inorg. Chim. Acta. 239: 133-138.
27. Lee, Y. A., O. S. Jung, and Y. S. Sohn. 1995. Synthesis and properties of diamine(isopropylidemalonato) platinum (II): crystal structure of O(CH2CH2)2C(CH2NH2)2P-t(OOC)2C = C(CH3)2 Polyhedron. 14: 2099-2106.
28. Pregrosin, P. S. 1986. Platinum NMR spectroscopy. Annu. NMR Spedrosc. 17: 285-349.
29. Kortes, R. A., F. T. Lin, R. E. Shepherd, and C. Maricondi. 1996. pH dependent coordination of the glycinato donors of nitrilotriacetatoplatinate(II). Inorg. Chim. Acta. 245: 149-156.
30. Minghetti, G., M. A. Cinellu, S. Stoccoro, A. Zucca, and M. Manassero. 1995. Cyclometallated derivatives of Platinum(II) derived from 6-(tert-butyl)-2,2′, bipyridine (HL). Crystal and molecular structure of [Pt(L)Cl]. J. Chem. Soc. Dalton Transc. 7: 777-779.
31. Wood, K. V., Y. Sun, and R. G. Elkin. 1991. Differentiation of isomeric conjugated bile acids using positive-ion B/E linked scans. Anal. Chem. 63: 247-250.
32. Mingrone, G., A. V. Greco, L. Boniforti, and S. Passi. 1983. Analysis of conjugate bile acids by high performance liquid chromatography and mass spectrometry. Lipids. 18: 90-95.
33. Lever, A. B. P. 1984. Inorganic Electronic Spectroscopy. 2nd ed. Elsevier Science Publishers, Amsterdam.
34. Jestin, J. L., J. C. Chottard, U. Frey, G. Larenczy, and A. E. Merbach. 1994. Mechanism of aquation of bicycloalkyl-substituted (ethylenediammine)dichloroplatinum(II) complexes: a search for the understanding of their differences in antitumor activity. Inorg. Chem. 33: 4277-4282.
35. Berners-Price, S. J., U. Frey, J. D. Ranford, and P. J. Sadler. 1993. Stereospecific hydrogen-bonding in mononucleotide adducts of platinum anticancer complexes in aqueous solution. J. Am. Chem. Soc. 115: 8649-8659.
36. Miller, S. E., and D. A. House. 1989. The hydrolysis products of cis-dichlorodiammineplatinum(II). 2. The kinetics of formation and anation of the cis-diamminedi(aqua)platinum(II) cation. Inorg. Chim. Acta. 166: 189-197.
37. 195Pt NMR and mechanistic studies of cis-and trans-diamminedichloroplatinum(II) binding to DNA. J. Am. Chem. Soc. 112: 6860-6871.
38. Barbero, E. R., M. C. Herrera, M. J. Monte, M. A. Serrano, and J. J. G. Marin. 1995. Role of amidation in bile acid effect on DNA synthesis by regenerating mouse liver. Am. J. Physiol. 31: G1051-G1059.